Your browser doesn't support javascript.
loading
Cancer Prognosis Defined by the Combined Analysis of 8q, PTEN and ERG.
Silva, Maria P; Barros-Silva, João D; Ersvær, Elin; Kildal, Wanja; Hveem, Tarjei Sveinsgjerd; Pradhan, Manohar; Vieira, Joana; Teixeira, Manuel R; Danielsen, Håvard E.
Affiliation
  • Silva MP; Department of Genetics, Portuguese Oncology Institute of Porto (IPO Porto), Porto, Portugal; Cancer Genetics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), Porto, Portugal.
  • Barros-Silva JD; Department of Genetics, Portuguese Oncology Institute of Porto (IPO Porto), Porto, Portugal; Cancer Genetics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), Porto, Portugal.
  • Ersvær E; Institute for Cancer Genetics and Informatics, Oslo University Hospital, Oslo, Norway; Center for Cancer Biomedicine, University of Oslo, Oslo, Norway.
  • Kildal W; Institute for Cancer Genetics and Informatics, Oslo University Hospital, Oslo, Norway; Center for Cancer Biomedicine, University of Oslo, Oslo, Norway.
  • Hveem TS; Institute for Cancer Genetics and Informatics, Oslo University Hospital, Oslo, Norway; Center for Cancer Biomedicine, University of Oslo, Oslo, Norway; Department of Informatics, University of Oslo, 0310 Oslo, Norway.
  • Pradhan M; Institute for Cancer Genetics and Informatics, Oslo University Hospital, Oslo, Norway; Center for Cancer Biomedicine, University of Oslo, Oslo, Norway.
  • Vieira J; Department of Genetics, Portuguese Oncology Institute of Porto (IPO Porto), Porto, Portugal.
  • Teixeira MR; Department of Genetics, Portuguese Oncology Institute of Porto (IPO Porto), Porto, Portugal; Cancer Genetics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), Porto, Portugal; Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, Po
  • Danielsen HE; Institute for Cancer Genetics and Informatics, Oslo University Hospital, Oslo, Norway; Center for Cancer Biomedicine, University of Oslo, Oslo, Norway; Department of Informatics, University of Oslo, 0310 Oslo, Norway; Nuffield Division of Clinical Laboratory Sciences, University of Oxford, Oxford, U
Transl Oncol ; 9(6): 575-582, 2016 Dec.
Article in En | MEDLINE | ID: mdl-27916292

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Transl Oncol Year: 2016 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Transl Oncol Year: 2016 Document type: Article Affiliation country: Country of publication: